CFD RESEARCH CORPORATION — Department of Defense STTR Phase I: CBD18A-001

Description

In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and rapid diagnostics.We propose to undertake a systematic study to identify and validate the circulatory RNAs and the potential exosomal-based biomarkers ofVEEV infection using mouse models. Multiple clinical matrices (urine, blood, CSF, lymph) and infection routes (intranasal, subcutaneous) will bestudied to analyze the RNA biomarker dynamics in a specified diagnostic window (0-14 days, post infection). Exosome contents (e.g., miRNA)and other host-based biomarkers will also be analyzed and compared for specificity and sensitivity. Finally, we will integrate the animaloutcome in computational models to predict viral kinetics, translation of findings from animals to humans, and to make predictions ofprognostic factors for treatment efficacy and the risk of relapse and progression. Ultimately, we envision to develop a low cost, in vitrodiagnostic device for rapid and sensitive detection of pre-symptomatic, symptomatic or convalescent biomarkers of these infectious diseases.